Canadian Cancer Trials Group Bulletins

Trial Management Group


Trials Closed to Accrual

GAC.1 / CALGB 80101 -- Phase III Intergroup trial of adjuvant chemoradiation after resection of gastric or gastroesophageal adenocarcinoma -- was closed to accrual after achieving its target accrual on 29 May 2009.
http://www.ctg.queensu.ca/trials/gastro-intestinal/gac1/gac1.html

IND.162 -- A phase I study of RAD001C in combination with temozolomide in patients with glioblastoma multiforme - was closed to accrual on 1 June 2009.
http://www.ctg.queensu.ca/trials/ind/i162/162.html